Home/Filings/4/0001209191-20-048990
4//SEC Filing

DUGAN MICHAEL C 4

Accession 0001209191-20-048990

CIK 0001044378other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 9:15 PM ET

Size

5.4 KB

Accession

0001209191-20-048990

Insider Transaction Report

Form 4
Period: 2020-08-31
DUGAN MICHAEL C
Chief Med Off & Med. Director
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-08-31+54,90054,900 total
    Exercise: $0.67Exp: 2030-08-30Common Stock (54,900 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (8/18/2021) with the balance vesting in equal monthly installments thereafter until fully vested on August 18, 2024.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeother

Related Parties

1
  • filerCIK 0001239105

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 9:15 PM ET
Size
5.4 KB